University of Miami's 2nd Biennial Miami Leukemia Symposium

 

ALL Biology and Treatment
24:06

University of Miami's 2nd Biennial Miami Leukemia Symposium

ALL Frontline Therapy for Young Adults: Building Upon a Successful “Backbone” With Addition of Targeted Agents to Eradicate MRD and Improve Tolerance/Decrease Toxicity

FEATURING Wendy Stock
  • 183 views
  • May 14, 2020
  • 1
20:50

University of Miami's 2nd Biennial Miami Leukemia Symposium

Relapsed/Refractory ALL: Both Inotuzumab and Blinatumomab Are Superior to Standard Chemotherapy With Regards to Remission Rates and Survival

FEATURING Daniel J. DeAngelo
  • 297 views
  • May 14, 2020